HomeAI · summaries
Storia in 5 fonti
BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
BAXFENDY approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
astrazeneca.com
Baxfendy approved in the US as the first and only aldosterone synthase inhibitor treatment for adults with hypertension
AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with…
- ·
healio.com
Baxfendy approved for uncontrolled hypertension
AstraZeneca announced the FDA approved baxdrostat for uncontrolled hypertension as add-on therapy on top of standard care.Baxdrostat (Baxfendy) is the first aldosterone synthase…
